Trademark: 97493218
Status Date
Tuesday, January 2, 2024
Filing Date
Thursday, July 7, 2022
Published for Opposition
Tuesday, November 7, 2023
40 Custom manufacture of biomedical compounds comprised of nucleotide polymers or biomedical compounds comprised of ribonucleic acid polymers for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders
5 Pharmaceutical preparations for the treatment of rare genetic diseases; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of ribonucleic acid polymers for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; RNA therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use in RNA editing; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use in base editing; Pharmaceutical preparations containing biomedical compounds comprised of nucleotide polymers for use as RNA therapeutic for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics for the treatment of genetic diseases and the repair and modulation of disease causing mutations and protein function; Pharmaceuticals, namely, bio-pharmaceutical preparations for the treatment of rare diseases
42 Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Research and development of pharmaceutical products; Research and development in the field of bioscience; Research and development of biomedical compounds comprised of nucleotide polymers for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; Research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; Research and development of biomedical compounds comprised of nucleotide polymers for targeted RNA editing; Research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders
Jan 2, 2024
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2023
Published For Opposition
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Sep 30, 2023
Approved For Pub - Principal Register
Sep 29, 2023
Teas/Email Correspondence Entered
Sep 29, 2023
Correspondence Received In Law Office
Sep 29, 2023
Teas Response To Office Action Received
Aug 28, 2023
Application Extension Granted/Receipt Provided
Aug 28, 2023
Application Extension To Response Period - Received
May 31, 2023
Notification Of Non-Final Action E-Mailed
May 31, 2023
Non-Final Action E-Mailed
May 31, 2023
Non-Final Action Written
May 25, 2023
Teas Change Of Correspondence Received
May 25, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 15, 2023
Previous Allowance Count Withdrawn
May 9, 2023
Withdrawn From Pub - Og Review Query
Apr 27, 2023
Approved For Pub - Principal Register
Apr 20, 2023
Assigned To Examiner
Jul 26, 2022
New Application Office Supplied Data Entered
Jul 11, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
